Researchers at four centers in France will evaluate the safety and effectiveness of apremilast, an approved oral psoriasis therapy, in…
Articles by Steve Bryson, PhD
Scientists traced a common genetic mutation that causes recessive dystrophic epidermolysis bullosa (RDEB) to the Sephardic Jewish population, a…
Vyjuvek (beremagene geperpavec) successfully healed widespread skin wounds on an infant boy with severe dystrophic epidermolysis bullosa (DEB),…
A buildup of pro-inflammatory signaling molecules in skin wounds may explain the slow healing process experienced…
Treatment with dupilumab, a medicine approved for certain inflammatory disorders, eases itch and disease severity in people with different subtypes…
The stem cell therapy CORDStrom, in the pipeline at Inmune Bio, was found in a clinical trial to reduce…
A topical ointment containing diacerein, an arthritis medication, promoted wound healing in a 5-year-old girl with hard-to-treat recessive dystrophic…
Adults with recessive dystrophic epidermolysis bullosa (RDEB) have abnormal immune cell profiles in blood and skin samples, a study…
Becoming a self-taught provider of home-based skin care is one of the many challenges faced by parents of children with…
Treatment with losartan, a commonly used oral blood pressure medication, safely reduced the signs and symptoms of recessive dystrophic…
Two brothers shared a mild but distinct form of junctional epidermolysis bullosa (JEB) that affected the teeth, nails, and…
The experimental therapy ELX-02 reversed the effect of nonsense mutations in skin cells derived from people with recessive dystrophic…